CYTOCOM
DEAD

Serial Number

90318173

Owner

Cytocom, Inc.

Attorney

John J. O'Malley

Filing Date

Nov 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CYTOCOM Trademark

Serial Number: 90318173

CYTOCOM is a trademark filed by Cytocom, Inc. on November 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Cytocom, Inc. (6 trademarks)

One North Broadway, 8th Floor
White Plains, NY 10606

Entity Type: 03

Trademark Details

Filing Date

November 13, 2020

Registration Date

Not Registered

Goods & Services

Educational services, namely, conducting classes, seminars, conferences, and workshops in the medical, pharmaceutical, and healthcare fields and distributing printed course materials in conjunction therewith; providing online journals, namely, blogs in the medical, pharmaceutical and health fields

Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immunocompromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements

Medical and pharmaceutical research services; pharmaceutical research and development

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 13, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 13, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 13, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 27, 2022 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 29, 2022 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 10, 2022 RCCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 19, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 19, 2021 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 12, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 12, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
May 12, 2021 GNSL
SUSPENSION LETTER WRITTEN
May 12, 2021 CNSL
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 12, 2021 ZZZX
WITHDRAWN FROM PUB OTQR REQUEST
May 12, 2021 PBTQ
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 26, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 26, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 26, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 26, 2021 CNEA
ASSIGNED TO EXAMINER
Apr 23, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2021 NWOS
NEW APPLICATION ENTERED
Nov 17, 2020 NWAP